Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of esophageal cancer.

× No keyword cloud information.

16 in total

1. Postoperative complications in patients of esophageal cancer after neoadjuvant chemotherapy.

Authors: J Minamide; N Aoyama; H Koizumi; K Yoneyama; S Hoshino; J Kamiya; S Tamai; Y Kameda
Journal: Jpn J Thorac Cardiovasc Surg Date: 1999-11

2. Laser therapy for esophageal cancer. Results and additional endoscopic treatments.

Authors: T T Zittel; D Allgaier; K E Grund
Journal: Surg Endosc Date: 1994-09 Impact factor: 4.584

Review 3. Surgery for carcinoma of the oesophagus.

Authors: A Watson
Journal: Postgrad Med J Date: 1988-11 Impact factor: 2.401

4. Bypass operation for advanced esophageal cancer--an analysis of 93 cases.

Authors: T Hirai; Y Yamashita; H Mukaida; K Kawano; T Toge; M Niimoto; T Hattori
Journal: Jpn J Surg Date: 1989-03

5. The usefulness of cyclophosphamide pretreatment for subrenal capsule assay against human esophageal cancer.

Authors: M Terashima; K Ikeda; S Kawamura; C Maesawa; K Ishida; M Sato; K Saito
Journal: Jpn J Surg Date: 1991-03

6. Preoperative chemotherapy in esophageal carcinoma.

Authors: D P Kelsen
Journal: World J Surg Date: 1987-08 Impact factor: 3.352

Review 7. Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1986-08 Impact factor: 1.798

8. Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.

Authors: D M Nanus; D P Kelsen; R Lipperman; M Eisenberger
Journal: Invest New Drugs Date: 1988-09 Impact factor: 3.850

Review 9. Cancer of the esophagus: the Wayne State University experience.

Authors: L Leichman
Journal: Invest New Drugs Date: 1989-04 Impact factor: 3.850

10. Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.

Authors: Tadasuke Hashiguchi; Motomi Nasu; Takashi Hashimoto; Tetsuji Kuniyasu; Hirohumi Inoue; Noritaka Sakai; Kazutomo Ouchi; Takayuki Amano; Fuyumi Isayama; Natsumi Tomita; Yoshimi Iwanuma; Masahiko Tsurumaru; Yoshiaki Kajiyama
Journal: Mol Clin Oncol Date: 2014-06-19